Structural Formula (Posaconazole Delayed Release Tablets 1)
Posaconazole Tablet, Delayed Release
Product Images NDC 69238-1476
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 69238-1476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
30ct Label (Posaconazole Delayed Release Tablets 2)
This is a description of a package of Posaconazole Delayed-Release Tablets, each tablet containing 100mg posaconazole. The dosing instructions are provided in the package insert. The tablets should be stored at a temperature between 20°C to 25°C with excursions allowed to between 15°C to 30°C. It is mentioned that Noxafil oral suspension and posaconazole delayed-release tablets are not interchangeable due to differences in dosing. The package contains 30 tablets and a non-varnish area for lot number, expiration date, and serialization. The text also details the trademarks referenced in the package and the company distributing it.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
